Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Rituximab

EU orphan designation number: EU/3/17/1869   
Active ingredient: Rituximab
Indication: Treatment in solid organ transplantation
Sponsor: Hôpital Foch
40 rue Worth, 92150 Suresnes, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/04/2017 Orphan designation EMA/OD/286/16 (2017)2788 of 20/04/2017